Epilepsy
The NeurologyLive® epilepsy clinical focus page provides information, podcasts, videos, and news about the latest FDA actions, clinical guideline updates, study and clinical trial findings, and interviews with physicians related to epilepsy and related epileptic conditions, including Lennox-Gastaut syndrome, Dravet syndrome, tuberous sclerosis complex, focal seizures, nonmotor seizures, and more.
Check out some of NeurologyLive®'s featured content in the carousel below.
More News
Recommendations for Treating Epilepsy in the Clinical Space: Christopher Elder, MD
September 20th 2022The clinical assistant professor of neurology in the Comprehensive Epilepsy Center at NYU Langone Health gives recommendations for clinical care on prescribed antiseizure medication and RNA therapy. [WATCH TIME: 5 minutes]
Celebrating the Expansion and Stressing the Importance of Newborn Screening
September 17th 2022The explosion of new science and legislative decisions have expanded the capabilities and reach of newborn screening, providing thousands of families every year an opportunity to seek early, and critical, care for their infants.
The Future of Clinical Care with New Antiseizure Medication: Christopher Elder, MD
September 14th 2022An overview of the shifting landscape of antiseizure medication and various neurostimulation devices is shared by the clinical assistant professor of neurology in the Comprehensive Epilepsy Center at NYU Langone Health. [WATCH TIME: 5 minutes]
Future Implications, Outlook of New CDC Developmental Milestone Guidelines: Paul Lipkin, MD
September 13th 2022The director of medical outpatient services at the Kennedy Krieger Institute discussed the long-term effects of the updated developmental milestone guidelines and the need to judge children based on the 75th percentile. [WATCH TIME: 7 minutes]
The Rise of Neurostimulation in Epilepsy Care: Christopher Elder, MD
September 6th 2022The clinical assistant professor of neurology in the Comprehensive Epilepsy Center at NYU Langone Health shared an overview of the various neurostimulation devices that have made their way into the clinical care of seizure disorders. [WATCH TIME: 4 minutes]
Changes in Practice, Perspective on Developmental Milestones for Children: Paul Lipkin, MD
September 3rd 2022The director of medical outpatient services at the Kennedy Krieger Institute provided insight on how clinicians have typically assessed children who fail to meet milestones, and how that might change with new guidelines. [WATCH TIME: 3 minutes]
Sirolimus Topical Gel Available for Facial Angiofibroma Associated With Tuberous Sclerosis Complex
August 30th 2022The 0.2% topical gel, branded as Hyftor by Nobelpharma America, was approved in March 2022, and is indicated for individuals aged 6 years and older with TSC. It is the first topical therapy approved for this population.
FDA Approves Midazolam Autoinjector for Status Epilepticus
August 30th 2022The Rafa Laboratories 10-mg midazolam autoinjector is the first in market product of its kind, adding another option for the rescue of individuals with status epilepticus, a condition with crucial time implications in treatment.
Causative and Unknown Etiology MRI Abnormalities Both Common in Newly Diagnosed Focal Epilepsy
August 30th 2022Younger patients were more likely to have epilepsy-related imaging abnormalities, while older patients were more likely to have incidental abnormalities or those with an unknown relationship to epilepsy.
Overview of New CDC Developmental Milestones for Young Children: Paul Lipkin, MD
August 30th 2022The director of medical outpatient services at the Kennedy Krieger Institute provided insight on the recently announced revisions to the “Learn the Signs. Act Early.” CDC developmental milestones for children. [WATCH TIME: 4 minutes]
